Fingerprint
Dive into the research topics of 'Nrf2 activation confers resistance to eif4a inhibitors in cancer therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nrf2 activation confers resistance to eif4a inhibitors in cancer therapy
Viraj R. Sanghvi, Prathibha Mohan, Kamini Singh, Linlin Cao, Marjan Berishaj, Andrew L. Wolfe, Jonathan H. Schatz, Nathalie Lailler, Elisa de Stanchina, Agnes Viale, Hans Guido Wendel
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations